ARCHIVES

FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

Professional Societes; ASCO’s Strength Is In Its Diversify, Lichtor Says

May 21, 1999

New NCI division For Center, Training, Organ Systems, Construction Seen As Likely Prospect

April 17, 1987

Race, Age Play Role In Delay Of Surgery For Breast Cancer

December 28, 2007

NCI Considering Master Agreements For Cancer Centers

August 2, 1991

ACCR Considers Foriend Membership, Meeting With ASCO

June 14, 1991

Obituary: Sydney Salmon, 63, Founding Director, Arizona Cancer Center

October 15, 1999